Načítá se...

Drug-induced immune-mediated thrombocytopenia secondary to sunitinib in a patient with metastatic renal cell carcinoma: a case report

INTRODUCTION: Sunitinib is an oral multi-targeted tyrosine kinase inhibitor approved for first line treatment for metastatic renal cell carcinoma and imatinib-resistant metastatic gastrointestinal stromal tumors. Sunitinib administration can cause myelosuppression resulting in neutropenia and thromb...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ansari, Zia, George, Mathew K
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3599754/
https://ncbi.nlm.nih.gov/pubmed/23442444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-7-54
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!